Evidence map›Paper›PMID 36923635›Full record

ArticleNagoya journal of medical science2023

<Editors' Choice> Myelodysplastic syndrome with trisomy 8 presenting periodic fever and multiple

Noriyuki Takahashi, Ryo Hanajiri, Masashi Suzuki, Chise Anan, Atsushi Inagaki, Dai Kishida, Shohei Ozawa, Sho Kohri, Nobuhide Kamiya, Motoki Sato and 1 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in Nagoya journal of medical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Behçet-like Syndromes: A Comprehensive Review.Dermatopathology (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Noriyuki TakahashiDepartment of Education for Community-Oriented Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ryo HanajiriDepartment of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Masashi SuzukiDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Chise AnanDepartment of Neurology, NTT West Tokai Hospital, Nagoya, Japan.
Atsushi InagakiDepartment of Hematology and Oncology, Nagoya City University West Medical Center, Nagoya, Japan.
Dai KishidaDepartment of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan.
Shohei OzawaDepartment of General Medicine, Nagoya University Hospital, Nagoya, Japan.
Sho KohriDepartment of General Medicine, Nagoya University Hospital, Nagoya, Japan.
Nobuhide KamiyaDepartment of General Medicine, Meitoh Hospital, Nagoya, Japan.
Motoki SatoDepartment of General Medicine, Nagoya University Hospital, Nagoya, Japan.
Juichi SatoDepartment of General Medicine, Nagoya University Hospital, Nagoya, Japan.
Nagoya University Hospital · JPNagoya University · JPNagoya City University · JPShinshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myelodysplastic syndrome is associated with the development of autoinflammatory conditions, such as recurrent fever, polymyalgia, arthralgia, and erythema. Trisomy 8 is a common chromosomal abnormality in patients with myelodysplastic syndrome. Myelodysplastic syndrome with trisomy 8 involves autoinflammatory conditions, especially Beh

Indexed as

autoinflammatory diseaseMEFV genemyelodysplastic syndrometrisomy 8

Identifiers

PMID36923635
PMCPMC10009629
OpenAlexW4327675417

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.